Jun 03, 2022

Shareholder Newsletter June 2022

Shareholder Newsletter June 2022

The Starpharma Holdings Limited (ASX: SPL, OTCQX: SPHRY) Shareholder Newsletter June 2022 is now available to view online.

In this issue:

>> New data for SPL7013 in VIRALEZE™ against influenza and Omicron 

>> VIRALEZE™ to relaunch in the UK

>> AstraZeneca expands the clinical program for their DEP® agent, AZD0466

>> Business development and conferences

>> Internal DEP® clinical programs and clinical case studies

>> DEP® gemcitabine clinical study to commence shortly

>> Partnered DEP® programs

>> International rollout of VIRALEZE™

>> New peer-reviewed publication of VivaGel® BV in Archives of Gynecology & Obstetrics

>> Okamoto launches new VivaGel® condom brand in Japan  

>> Quarterly Cashflow, Our People, Key Value Drivers & Outlook


Download: Shareholder Newsletter June 2022 (pdf file, 671kb)

 This contains certain forward-looking statements.